Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Products
  • Cinacalcet Hydrochloride Tablets
Where it was sold

Nationwide in the USA

Nationwide

Units affected
113,336 bottles
About this recall
Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02